Literature DB >> 10848826

Prenatal and peripartum management of congenital afibrinogenaemia.

T Kobayashi1, N Kanayama, N Tokunaga, T Asahina, T Terao.   

Abstract

We experienced three cases and four successful deliveries with congenital afibrinogenaemia and propose the following guidelines for the prenatal and peripartum management: (i) genital bleeding usually begins at 5 weeks' gestation and spontaneous abortion always occurs at 6-8 weeks' gestation without fibrinogen infusion; (ii) the fibrinogen level must be at least 0.60 g/l and, if possible, higher than 1.0 g/l during the pregnancy; (iii) the necessary amounts of fibrinogen increase as the pregnancy progresses and the preterm labour occurs; (iv) the fibrinogen level under the continuous infusion of fibrinogen during labour must be at least 1.5 g/l and, if possible, higher than 2.0 g/l to prevent placental abruption; (v) the puerperium is usually uneventful with a reduced dose of fibrinogen infusion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10848826     DOI: 10.1046/j.1365-2141.2000.01993.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  16 in total

1.  Management of dysfibrinogenemia in pregnancy: A case report.

Authors:  Jie Yan; Donghong Deng; Peng Cheng; Lin Liao; Meiling Luo; Faquan Lin
Journal:  J Clin Lab Anal       Date:  2017-09-26       Impact factor: 2.352

2.  Fibrinogen stabilizes placental-maternal attachment during embryonic development in the mouse.

Authors:  Takayuki Iwaki; Mayra J Sandoval-Cooper; Melissa Paiva; Takao Kobayashi; Victoria A Ploplis; Francis J Castellino
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

Review 3.  Prophylaxis of bleeding episodes and surgical interventions in patients with rare inherited coagulation disorders.

Authors:  Giancarlo Castaman
Journal:  Blood Transfus       Date:  2008-09       Impact factor: 3.443

Review 4.  Rare congenital bleeding disorders.

Authors:  Massimo Franchini; Giuseppe Marano; Simonetta Pupella; Stefania Vaglio; Francesca Masiello; Eva Veropalumbo; Vanessa Piccinini; Ilaria Pati; Liviana Catalano; Giancarlo Maria Liumbruno
Journal:  Ann Transl Med       Date:  2018-09

Review 5.  Update on inherited disorders of haemostasis and pregnancy.

Authors:  Orly Lavee; Giselle Kidson-Gerber
Journal:  Obstet Med       Date:  2016-01-20

Review 6.  Clinical Consequences and Molecular Bases of Low Fibrinogen Levels.

Authors:  Marguerite Neerman-Arbez; Alessandro Casini
Journal:  Int J Mol Sci       Date:  2018-01-08       Impact factor: 5.923

7.  Recurrent massive haemoperitoneum associated with ruptured corpus luteum in women with congenital afibrinogenemia; case report.

Authors:  Özhan Özdemir; Mustafa Erkan Sarı; Aslıhan Kurt; Ertuğrul Şen; Cemal Reşat Atalay
Journal:  Turk J Obstet Gynecol       Date:  2014-12-15

Review 8.  Diagnosis and Treatment of von Willebrand Disease and Rare Bleeding Disorders.

Authors:  Giancarlo Castaman; Silvia Linari
Journal:  J Clin Med       Date:  2017-04-10       Impact factor: 4.241

Review 9.  Treatment of congenital fibrinogen deficiency: overview and recent findings.

Authors:  Konstantinos Tziomalos; Sofia Vakalopoulou; Vassilios Perifanis; Vassilia Garipidou
Journal:  Vasc Health Risk Manag       Date:  2009-10-12

10.  Afibrinogenemia Diagnosed During Pregnancy Successfully Managed with Targeted Cryoprecipitate Transfusion: A Case Report.

Authors:  Athulya Shajan; Neetha George; Sareena Gilvaz; Siju V Abraham
Journal:  J Obstet Gynaecol India       Date:  2020-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.